Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 236

    1.

    Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial.

    Baum HB, Biller BM, Finkelstein JS, Cannistraro KB, Oppenhein DS, Schoenfeld DA, Michel TH, Wittink H, Klibanski A.

    Ann Intern Med. 1996 Dec 1;125(11):883-90.PMID: 8967668 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.

    Nass R, Pezzoli SS, Oliveri MC, Patrie JT, Harrell FE Jr, Clasey JL, Heymsfield SB, Bach MA, Vance ML, Thorner MO.

    Ann Intern Med. 2008 Nov 4;149(9):601-11.PMID: 18981485 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial.

    Hoffman AR, Kuntze JE, Baptista J, Baum HB, Baumann GP, Biller BM, Clark RV, Cook D, Inzucchi SE, Kleinberg D, Klibanski A, Phillips LS, Ridgway EC, Robbins RJ, Schlechte J, Sharma M, Thorner MO, Vance ML.

    J Clin Endocrinol Metab. 2004 May;89(5):2048-56.PMID: 15126520 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.

    Amato G, Mazziotti G, Di Somma C, Lalli E, De Felice G, Conte M, Rotondi M, Pietrosante M, Lombardi G, Bellastella A, Carella C, Colao A.

    J Clin Endocrinol Metab. 2000 Oct;85(10):3720-5.PMID: 11061530 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency.

    Biller BM, Sesmilo G, Baum HB, Hayden D, Schoenfeld D, Klibanski A.

    J Clin Endocrinol Metab. 2000 Mar;85(3):970-6.PMID: 10720025 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.

    Fernholm R, Bramnert M, Hägg E, Hilding A, Baylink DJ, Mohan S, Thorén M.

    J Clin Endocrinol Metab. 2000 Nov;85(11):4104-12.PMID: 11095440 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.

    Ahmad AM, Hopkins MT, Thomas J, Ibrahim H, Fraser WD, Vora JP.

    Clin Endocrinol (Oxf). 2001 Jun;54(6):709-17.PMID: 11422104 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effects of long-term treatment with GH in the bone mineral density of adults with hypopituitarism and GH deficiency and after discontinuation of GH replacement.

    Gómez JM, Gómez N, Fiter J, Soler J.

    Horm Metab Res. 2000 Feb;32(2):66-70.PMID: 10741688 [PubMed - indexed for MEDLINE]Related articles

    9.

    One year of GH replacement therapy with a fixed low-dose regimen improves body composition, bone mineral density and lipid profile of GH-deficient adults.

    Boguszewski CL, Meister LH, Zaninelli DC, Radominski RB.

    Eur J Endocrinol. 2005 Jan;152(1):67-75.PMID: 15762189 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.

    Cuneo RC, Judd S, Wallace JD, Perry-Keene D, Burger H, Lim-Tio S, Strauss B, Stockigt J, Topliss D, Alford F, Hew L, Bode H, Conway A, Handelsman D, Dunn S, Boyages S, Cheung NW, Hurley D.

    J Clin Endocrinol Metab. 1998 Jan;83(1):107-16.PMID: 9435425 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa.

    Grinspoon S, Baum H, Lee K, Anderson E, Herzog D, Klibanski A.

    J Clin Endocrinol Metab. 1996 Nov;81(11):3864-70.PMID: 8923830 [PubMed - indexed for MEDLINE]Related articles

    12.

    Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.

    Fideleff HL, Boquete HR, Stalldecker G, Giaccio AV, Sobrado PG.

    Growth Horm IGF Res. 2008 Aug;18(4):318-24. Epub 2008 Mar 4.PMID: 18289903 [PubMed - indexed for MEDLINE]Related articles

    13.

    Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study.

    Underwood LE, Attie KM, Baptista J; Genentech Collaborative Study Group.

    J Clin Endocrinol Metab. 2003 Nov;88(11):5273-80.PMID: 14602761 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial.

    Sesmilo G, Biller BM, Llevadot J, Hayden D, Hanson G, Rifai N, Klibanski A.

    Ann Intern Med. 2000 Jul 18;133(2):111-22.PMID: 10896637 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Effects of growth hormone (GH) replacement on bone metabolism and mineral density in adult onset of GH deficiency: results of a double-blind placebo-controlled study with open follow-up.

    Finkenstedt G, Gasser RW, Höfle G, Watfah C, Fridrich L.

    Eur J Endocrinol. 1997 Mar;136(3):282-9.PMID: 9100553 [PubMed - indexed for MEDLINE]Related articles

    16.

    Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study.

    Vahl N, Juul A, Jørgensen JO, Orskov H, Skakkebaek NE, Christiansen JS.

    J Clin Endocrinol Metab. 2000 May;85(5):1874-81.PMID: 10843168 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism.

    Beshyah SA, Thomas E, Kyd P, Sharp P, Fairney A, Johnston DG.

    Clin Endocrinol (Oxf). 1994 Mar;40(3):383-91.PMID: 8187303 [PubMed - indexed for MEDLINE]Related articles

    18.

    The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study.

    Drake WM, Rodríguez-Arnao J, Weaver JU, James IT, Coyte D, Spector TD, Besser GM, Monson JP.

    Clin Endocrinol (Oxf). 2001 Apr;54(4):525-32.PMID: 11318789 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients.

    Longobardi S, Di Rella F, Pivonello R, Di Somma C, Klain M, Maurelli L, Scarpa R, Colao A, Merola B, Lombardi G.

    J Endocrinol Invest. 1999 May;22(5):333-9.PMID: 10401706 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data